Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deoxycoformycin in Lymphoid Malignancies
NCT00038025Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Sep 1994
- Primary completion
- Nov 2006
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of pentostatin in peripheral T-cell lymphoma (PTCL), cutaneous T-cell lymphoma (CTCL) and chronic lymphocytic leukemia (CLL), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Number of Participants with Overall Response. Started Sep 1994; status: completed.
02
Drugs
pentostatin
03
Conditions
peripheral T-cell lymphoma (PTCL)cutaneous T-cell lymphoma (CTCL)chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00038025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00038025.